GBIO Live signals | Maximize Profits with Getagraph.com

SELL 128058 min ago

@ $1.880

Issued: 13 Feb 2024 @ 15:30

Return: 59.05%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -6.04 %

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 16:00):

Stats
Today's Volume	117 915
Average Volume	242 556
Market Cap	198.80M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $-0.360 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.530
ATR14	$0.00300 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Stanton Matthew	Buy	1 674	Common Stock
2024-04-15	Stanton Matthew	Sell	492	Common Stock
2024-04-15	Stanton Matthew	Sell	1 674	Restricted Stock Units
2024-04-15	Samayoa Phillip	Buy	1 147	Common Stock
2024-04-15	Samayoa Phillip	Sell	337	Common Stock

INSIDER POWER
82.94
Last 100 transactions
Buy: 2 618 558 \| Sell: 231 211

Volume Correlation

Long: -0.22 (neutral)

Short: -0.79 (moderate negative)

Signal:(22.821) Neutral

Generation Bio Co Correlation

10 Most Positive Correlations
HEWG	0.94
TILE	0.937
PCAR	0.933
DAX	0.933
HOOD	0.932
CROX	0.931
CPRT	0.93
TRVI	0.929
MSTR	0.928
DDIV	0.926

10 Most Negative Correlations
PEAR	-0.909
VORB	-0.906
BRQS	-0.886
TWKS	-0.884
VIOT	-0.881
IRDM	-0.879
SSP	-0.879
PYR	-0.878
RGC	-0.876
AUUD	-0.875

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Generation Bio Co Correlation - Currency/Commodity

0.05
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.65
( moderate negative )

Generation Bio Co Financials

Annual	2023
Revenue:	$5.90M
Gross Profit:	$641 000 (10.86 %)
EPS:	$-1.960

FY	2023
Revenue:	$5.90M
Gross Profit:	$641 000 (10.86 %)
EPS:	$-1.960

FY	2022
Revenue:	$0
Gross Profit:	$-5.13M (0.00 %)
EPS:	$-2.27

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.10

Financial Reports:

No articles found.

Generation Bio Co

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Realtime updates for Generation Bio Co [GBIO]

Upcoming Earnings Alert